PHARM — Pharmiva AB (publ) Share News
0.000.00%
Last trade - 00:00HealthcareHighly Speculative
Brief: Pharmiva Q2 Oper Loss Narrows To SEK 6 Mln
Brief: Pharmiva, Peptonic Announce Merger Plan
Brief: Pharmiva AB Prelim Jan-May Operating Loss Narrows To SEK 8.9 Mln
Brief: Pharmiva Q1 Loss Before And After Tax Narrows To SEK 5.3 Mln
Operation With Farmasiet
Brief: Pharmiva Receives Patent For FOAM By European Patent Organization
Brief: Pharmiva Develops Its Business Strategy To Strengthen Profitability
Brief: Pharmiva Q3 Operating Loss Narrows To SEK 4.0 Mln
Brief: Pharmiva Rights Issue Subscribed To A Total Of About 64.9%
Brief: Pharmiva Announces Information Memorandum In Relation To Rights Issue
Brief: Pharmiva Q2 Loss Before And After Tax Widens To SEK 7.4 Mln
Brief: Pharmiva Signs Distribution Agreement With Meds For Sale Of Vernivia
Brief: Pharmiva Intensifies Dialogue With Potential Partners
Brief: Pharmiva Q1 Loss At SEK 6.2 Million
Brief: Pharmiva Carries Out Directed Issue
Brief: Pharmiva Signs Agreement With Oriola For Resale Of Vernivia
Brief: Pharmiva Names Anna Linton New CEO
Brief: European Patent Organization To Approve Pharmiva's Foam I-Patent
Brief: Pharmiva Q4 Loss Before And After Tax Widens To SEK 5.7 Mln